Skip to main
UCI
UCI logo

ETRACS UBS Bloomberg Constant Maturity Commodity Index TR ETN (UCI)

$0.00

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Buy UCI Stock

About ETRACS UBS Bloomberg Constant Maturity Commodity Index TR ETN (UCI)

The full company name is ETRACS CMCI Total Return ETN.
Market cap
Today's volume
Revenue (TTM)
Avg. daily volume1.43K
EBITDA (TTM)
Open
Price / earnings ratio
Today's range
Debt / equity
52 week range$10.13 - $15.25
5 year debt / equity
Beta (LTM)0.38x
Interest coverage
Dividend & yield$0.00 (0.00%)
Current ratio
Ex-dividend date
Next earnings
Dividend payable date

UCI Stock News

View all

Frequently Asked Questions (FAQ)

The 52-week high for UCI stock is $15.25. The current UCI stock price $undefined is 100.00% below its 52-week high

The 52-week low for UCI stock is $10.13. The current UCI stock price $undefined has increased 100.00% from its 52-week low

No, the UCI stock does not pay dividends to its shareholders

How to buy UCI stock on Public

  1. 1

    Sign up for a brokerage account on Public

    It’s easy to get started. You can sign up for an account directly on our website or by downloading the Public app for iOS or Android.

  2. 2

    Add funds to your Public account

    There are multiple ways to fund your Public account—from linking a bank account to making a deposit with a debit card or wire transfer.

  3. 3

    Choose how much you'd like to invest in UCI stock

    Navigate to the Explore page. Then, type UCI into the search bar. When you see UCI stock appear in the results, tap it to open up the purchase screen.

  4. 4

    Manage your investments in one place

    You can find your newly purchased UCI stock in your portfolio—alongside the rest of your stocks, ETFs, crypto, treasuries, and alternative assets.

Buy UCI Stock

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.